Linezolid Olikla

Linezolid, the active ingredient in Linezolid Olikla, is an oxazolidinone presented as an oral tablet for oral use. It treats infections caused by Gram‑positive bacteria, including skin and soft‑tissue infections and community‑acquired or nosocomial pneumonia.

GNH USA supplies Linezolid Olikla as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linezolid Olikla is an oxazolidinone antibiotic used to treat infections caused by Gram‑positive bacteria. - Skin and soft tissue infections: effective against methicillin‑resistant Staphylococcus aureus and other susceptible organisms. - Community‑acquired and nosocomial pneumonia: treats pneumonia caused by susceptible Gram‑positive pathogens. - Complicated infections caused by Gram‑positive bacteria: used for bacteremia, endocarditis and other serious infections when other agents are unsuitable.

Adverse reactions may occur with linezolid therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Metallic taste: altered taste perception. - Insomnia: difficulty sleeping.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Peripheral neuropathy: nerve pain or sensory changes. - Serotonin syndrome: risk when combined with serotonergic agents. - Severe anemia: marked reduction in red blood cells. - Elevated liver enzymes: potential hepatic injury. - Allergic reactions: including rash, angioedema or anaphylaxis.

Use of linezolid requires careful clinical monitoring. - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: assess liver enzymes regularly. - Concomitant serotonergic agents: avoid due to risk of serotonin syndrome. - Myelosuppression: perform periodic complete blood counts. - Hypersensitivity: discontinue if allergic reaction occurs. - Store at ambient temperature: keep below 25°C, retain in original packaging and protect from moisture.

Linezolid can interact with several drug classes.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis and serotonin syndrome. - SSRIs, SNRIs, or other serotonergic drugs: may precipitate serotonin syndrome. - Rifampin: induces metabolism, reducing linezolid plasma levels. - Warfarin: may increase anticoagulant effect and bleeding risk.

Moderate Interactions (Monitor Closely): - NSAIDs: additive effect on bleeding risk. - Diuretics: potential for hypotensive episodes. - Phenytoin: may alter linezolid concentrations, requiring monitoring.